Indoleamine 2,3-dioxygenase (IDO) Activity in Patients With Chronic Lymphocytic Leukemia (CLL)
Indoleamine 2,3-dioxygenase (IDO) Activity in Patients With Chronic Lymphocytic Leukemia (CLL)
The Activity of Indoleamine 2,3-dioxygenase in patients with Chronic Lymphocytic Leukemia
 (CLL) is studied.
The Activity of Indoleamine 2,3-dioxygenase in patients with Chronic Lymphocytic Leukemia
 (CLL)is studied in patients and healthly controls.
Inclusion Criteria:

 -  Patients with CLL and lymphocyte count > 10 x 109/l

 Exclusion Criteria:

 -  Acute infection